CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +9,500 | $45.28 | $430K | 56,435.72 |
| 2025-03-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −9,500 | $67.96 | $646K | 46,935.72 |
| 2025-03-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −9,500 | 9,500 | ||
| 2025-03-10 | Zovighian Bernard J CEO | Option exercise 10b5-1 | +7,463 | $45.28 | $338K | 66,545.9 |
| 2025-03-10 | Zovighian Bernard J CEO | Gift 10b5-1 | −1,299 | 65,246.9 | ||
| 2025-03-10 | Zovighian Bernard J CEO | Sale 10b5-1 | −6,164 | $69.51 | $428K | 59,082.9 |
| 2025-03-10 | Zovighian Bernard J CEO | Gift 10b5-1 | +1,299 | 10,436 | ||
| 2025-03-10 | Zovighian Bernard J CEO | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −7,463 | 7,462 | ||
| 2025-03-10 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +400 | $45.28 | $18K | 22,988.07 |
| 2025-03-10 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −400 | $69.48 | $28K | 22,588.07 |
| 2025-03-10 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −400 | 630 | ||
| 2025-02-28 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +11,250 | $45.28 | $509K | 41,637 |
| 2025-02-28 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −3,490 | $71.38 | $249K | 38,147 |
| 2025-02-28 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,760 | $70.52 | $547K | 30,387 |
| 2025-02-28 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −11,250 | 22,500 | ||
| 2025-02-22 | Dahl Andrew M. SVP, Corporate Controller | Shares withheld for taxes | −176 | $73.30 | $13K | 4,684.13 |
| 2025-02-18 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −222 | $76.19 | $17K | 22,588.07 |
| 2025-02-17 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −165 | $76.19 | $13K | 22,810.07 |
| 2025-02-16 | Lippis Daniel J. CVP, JAPAC | Shares withheld for taxes | −214 | $76.19 | $16K | 22,975.07 |
| 2025-02-16 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −174 | $76.19 | $13K | 30,387 |
Page 17 of 27 · 525 trades